The US Food and Drug Administration (FDA) has designated the Eversense (Senseonics, Inc; Ascencia Diabetes Care) implanted continuous glucose monitor (CGM) as an ‘integrated CGM,’
According to Drug Delivery Business, industry analysts are surprised at the increase in users of CGM within the non-insulin and basal insulin populations. William Blair
Poland-based Biotts, has become the world’s first company to successfully complete transdermal delivery of insulin (through the skin in the form of patches without injections).
The US Food and Drug Administration (FDA) has cleared Dexcom’s Stelo Glucose Biosensor System as the first over-the-counter continuous glucose monitoring (CGM) system. Unlike other
Blood glucose monitors are unnecessary for people without diabetes and could, in extreme cases, fuel eating disorders, leading doctors have warned. They are part of
Recent research has found that the average US adult scrolls the equivalent of three marathons a year on their phone. The study, commissioned by running
Insulet has announced positive results from a clinical trial showing improved glycemic and patient-reported outcomes in Type 1 diabetes with the Omnipod 5 automated insulin
New research has found that hybrid closed-loop (HCL) systems may ease severe diabetes distress in some adults with Type 1 diabetes, but not in adolescents.
Millions of people will now be able to use the NHS App to view their prescriptions for the first time. Following a successful trial last
Leading experts are calling for glucose monitoring technology – which is currently only available in the UK to people on intensive insulin therapy – to
